Close mobile menu×
Close mobile menu

Tamas A. Gonda, MD

Board Certifications: 
Gastroenterology, Internal Medicine
Expertise in: 
Pancreatic Cancer, Cancer Care
Accepting New Patients
Profile Headshot

Appointments

Phone Appointments

New and Existing Patients: 

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

Board Certifications

  • Gastroenterology
  • Internal Medicine

Clinical Expertise

  • Pancreatic Cancer
  • Cancer Care
  • Pancreatic Disease
  • Biliary Disease
  • Pancreatitis
  • Pancreatobiliary Disease

Education & Training

  • Dartmouth Medical School, NH
  • Internship: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
  • Residency: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
  • Residency: Memorial Sloan-Kettering Cancer Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Honors & Awards

  • Howard Hughes Medical Institute-NIH Research Scholar, 2002
  • ACG Clinical Research Award, 2009
  • Louis V. Gerstner, Jr. Scholars Award (Columbia University), 2010

About Tamas Gonda

Academic Titles

  • Associate Professor of Medicine at CUMC

Hospital Affiliations

  • NewYork-Presbyterian/Columbia
  • NewYork-Presbyterian/Weill Cornell

Gender

  • Male

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • NYP Employee Plan
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care

AgeWell

  • Medicare Managed Care
  • Special Needs Plan

Amida Care

  • Special Needs Plan

Capital District Physician Health Plan

  • Capital District Physician Health Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Elderplan

  • Medicare Managed Care

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • EPO
  • Medicare Managed Care
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs Plan

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
161 Fort Washington Avenue
Room 852A
New York, New York 10032
Primary

Research

Tamas Gonda, MD is an Associate Professor of Medicine in the Division of Digestive and Liver Diseases at Columbia University. His research area is pre-clinical and translational investigation of new therapeutic and chemoprevention targets in pancreatic and gastric malignancy. He has been funded by an NIH and AACR Innovator grants to study the effects of epigenetic modification on the tumor microenvironment. Most recently, his focus has been on the potential of epigenetic priming as a way to improve response to immunotherapy in pancreatic cancer. His clinical expertise is in pancreatobiliary diseases as an interventional gastroenterologist. As Director of Endoscopic Research at Columbia, he has been involved and served as principal investigator on several translational and early phase clinical studies in both pancreatic premalignant conditions and pancreatic cancer. His clinical and translational research interests include the area of early biomarkers in pancreatic cancer as well as the use of endoscopic targeted molecular markers and therapies.

Research Interests

  • Early detection of GI malignancies such as esophageal, pancreatic, biliary cancer

Grants

A PHASE 1, SINGLE DOSE PK AND SAFETY STUDY WITH NI-03 FOLLOWED BY A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP DOSE-RANGING STUDY TO EVALUATE THE SAFETY AND EFFICACY OF NI-03 COMPARED TO PLACEBO IN SUBJECTS WITH CHRONIC PANCREATITIS. (P&S Industry Clinical Trial)

Dec 20 2018 - Dec 20 2023

COMPARING FNA VS. FNB BIOPSIES FOR PANCREATIC ADENOCARCINOMA (P&S Industry Clinical Trial)

Nov 30 2018 - Nov 30 2023

PH1 STUDY OF T-VEC GIVEN ENDOSCOPICALLY FOR ADVANCED PANCREATIC CANCER IN 17248 (11/21/2016) (Federal Gov)

Aug 1 2018 - Jul 31 2021

TARGETING THE MICROENVIRONMENT IN GASTRIC CHEMOPREVENTION (Federal Gov)

Sep 1 2014 - Aug 31 2019

PRE-CLINICAL TESTING FOR SYNERGY OF DNA HYPOMETHYLATION + ANTI-PD1 AGAIST PDAC (Private)

Apr 1 2016 - Mar 31 2017

STEM CELLS AND THE ORIGINS OF BARRETT S ESOPHAGUS (Federal Gov)

Sep 26 2011 - Mar 31 2017

MOLECULAR CHARACTERIZATION OF BILIARY STRICTURES SUSPICIOUS FOR PANCREATIC AND CHOLANGIOCARCINOMA (Private)

Nov 10 2011 - Nov 9 2016

MYOFIBROBLASTS IN GASTROINTESTINAL CANCERS (Federal Gov)

Sep 22 2011 - Jul 31 2016

EPIGENETIC TARGETING OF THE MICROENVIRONMENT IN GASTRIC CHEMOPREVENTION (Private)

Jul 1 2014 - Jun 30 2016

QUANTITATIVE EVALUATION OF THE HISTOLOGIC CORRELATION AND POTENTIAL THERAPEUTIC BENEFIT OF FINE NEEDLE ASPIRATION VS. CORE TISSUE BIOPSIES IN PANCREATIC ADENOCARCINOMA STUDY (Private)

Sep 1 2014 - Aug 31 2015

EPIGENETIC PROFILING AND MODIFICATION IN BARRETT S ESOPHAGUS (Private)

Jul 1 2012 - Jun 30 2015

GLOBAL METHYLATION CHANGES IN BARRETT"S (Private)

Jul 1 2009 - Jun 30 2011

Selected Publications

  • Hasan A, Visrodia K, Farrell JJ, Gonda TA. Overview and comparison of guidelines for management of pancreatic cyctic neoplasms. World J Gastroenterol. 2019 Aug 21;25(31):4405-4413. PMID: 31496620
  • Gausman V, Kandel P, Van Riet PA, Moris M, Kayal M, Do C, Poneros JM, Sethi A, Gress FG, Schrope BA, Luk L, Hecht E, Jovani M, Bruno MJ, Cahen DL, Wallace MB, Gonda TA. Predictors of progression among low risk intraductal papillary mucinous neoplasms in a multicenter surveillance cohort. Pancreas. 2018; 47(4):471-476. PMID: 29521942
  • Mahadev S, Kumbhari V, Campos JM, Galvao Neto M, Khashab MA, Chavez YH, Bessler M, Gonda TA. Endoscopic septotomy: an effective approach for internal drainage of sleeve gastrectomy-associated collections. Endoscopy. 2017; 49(5):504-508. PMID: 28114687
  • Gonda TA,Varro A,Wang TC,Tycko B.Epigenetic changes in cancer associated fibroblasts.Sem Cell and Dev Biology 2010 Feb;21(1):2-10
  • Gonda TA,Tu S,Wang TC.Chronic Inflammation,tumor microenvironment and carcinogenesis.Cell Cycle 2009 Jul 1;8(13):2005-13.
  • Gonda TA,Khan SUZ,Cheng J ,Lewis SK,Rubin M,Green PHR.Intussusception and Celiac Disease.Digestive Dis.Sci.(in press)
  • Jiang L and Gonda TA.Gamble MV,Salas M,Seshan V,Tu S,Twaddell WS,Hegyi P,Lazar G,Steele I,Varro A,Wang TC,Tycko B.Global Hypomethylation of Genomic DNA in Cancer-Associated Myofibroblasts.(Cancer Res.2008 Dec 1;68(23):9900-8.) (Co- first author)
  • Papavasiliou AK,Magnadottir H,Gonda T,Franz D,Harbaugh RE.Clinical outcomes after carotid endarterectomy: comparison of the use of regional and general anesthetics.Journal of Neurosurgery.2000;92:921-926
  • Gonda T,Maouyo D,Rees SE,Montrose MH.Regulation of intracellular pH gradients by identified Na/H exchanger isoforms and short chain fatty acids.American Journal of Physiology "GI 1999;276: G259-270
  • Gonda T,Maouyo D,Rees SE,Montrose MH.Regulation of intracellular pH gradients by identified Na/H exchanger isoforms and short chain fatty acids.American Journal of Physiology "GI 1999;276: G259-270